Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Next Generation Sequencing in the Clinic Asia Summit 2017

Wei Ding's Biography



Wei Ding, Chief Scientific Officer, Admera Health

Dr. Wei Ding is the Chief Scientific Officer in Admera Health. He has over 19 years’ health care industry and academia experience, including the precision medicine, digital health and biomarker research. Prior to Admera, Dr. Ding worked as the clinical genomics lead at Mount Sinai from 2014 to 2016. Prior to Mount Sinai, he was the Principal Scientist at Schering Plough then Merck from 1999 to 2013. He worked as Fogarty Fellow in the National Center for Biotechnology Information (NCBI) from 1998 to 1999. He was also an adjunct professor at Kean University. Dr. Ding obtained his Ph.D. in Biophysics from the State University of New York at Stony Brook.

Wei Ding Image

Pharmacogenomics: A Key Component of Precision Medicine

Thursday, 30 November 2017 at 14:00

Add to Calendar ▼2017-11-30 14:00:002017-11-30 15:00:00Europe/LondonPharmacogenomics: A Key Component of Precision MedicineNext Generation Sequencing in the Clinic Asia Summit 2017 in Taipei, TaiwanTaipei, TaiwanSELECTBIOenquiries@selectbiosciences.com


Add to Calendar ▼2017-11-30 00:00:002017-11-30 00:00:00Europe/LondonNext Generation Sequencing in the Clinic Asia Summit 2017Next Generation Sequencing in the Clinic Asia Summit 2017 in Taipei, TaiwanTaipei, TaiwanSELECTBIOenquiries@selectbiosciences.com